18, 2024 — Scientists have generated human stem cell models which contain notochord ... could have implications ... How Breast Cancer Cells Survive in Bone Marrow After Remission Dec.

Dr. Sunita Tandulwadkar’s journey is a testament to her relentless pursuit of excellence, innovation, and service.

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...

Novel ADC shows activity in ovarian cancer Towards beta cell replacement therapy for diabetes! An upgraded pluripotent stem cell differentiation protocol is released Lurbinectedin, a new drug for ...

Margetuximab is under clinical development by MacroGenics and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I drugs for Cervical Cancer have an 80% phase transition success ...

INR:0159. register mybet88 Novaremed closes CHF 2.6 million funding round for diabetic neuropathic pain drug Another "Don't Eat Me" Signal Found! Ovarian Cancer ...

have developed a technology that transforms colon cancer cells into normal-like cells without destroying them. This innovative approach, led by Professor Kwang-Hyun Cho of the Department of Bio ...

By inhibiting the DNA polymerases, BKC enhances the endogenous RS in cancer cells, leading to increased DNA damage. IBC specifically inhibits CHK2 to prevent DNA repair. The combined use of BKC and ...

Larotrectinib sulfate is under clinical development by Bayer and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II drugs for Colorectal Cancer have a 25% phase transition ...

ovarian cancer progressing under taxane/carboplatin chemotherapy or in early relapse (< 6 months).

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.